Table 3.
Participant characteristics
| Young Adults | Midlife/Older Adults | |
|---|---|---|
| n (women/men) | 10 (5/5) | 10 (5/5) |
| Age, yr | 23.5 ± 1.0 | 67.2 ± 2.9* |
| Brachial-artery flow-mediated dilation, % | 9.3 ± 1.7 | 3.5 ± 0.5* |
| Carotid-femoral pulse wave velocity, m/s | 5.1 ± 1.7 | 8.5 ± 0.3* |
| Systolic blood pressure, mmHg | 112.6 ± 1.8 | 124 ± 2.9* |
| Diastolic blood pressure, mmHg | 64.8 ± 1.5 | 73.5 ± 2.1* |
| Body mass index, kg/m2 | 23.2 ± 1.1 | 25.0 ± 1.0 |
| Leisure time physical activity, MET h/wk | 52.6 ± 9.6 | 42.6 ± 5.9 |
| Total cholesterol, g/dL | 158 ± 18 | 188 ± 15 |
| HDL cholesterol, mg/dL | 52 ± 3 | 58 ± 9 |
| LDL cholesterol, mg/dL | 98 ± 12 | 107 ± 11 |
| Triglycerides, mg/dL | 113 ± 13 | 113 ± 18 |
| Fasting glucose, mg/dL | 90 ± 3 | 92 ± 2 |
| Medications | ||
| β-Blocker | 0/10 | 1/10 |
| Angiotensin II-receptor blocker | 0/10 | 1/10 |
| Ca2+-channel blocker | 0/10 | 2/10 |
| Statin | 0/10 | 2/10 |
| Thyroid hormone | 0/10 | 3/10 |
| Antidepressant | 0/10 | 4/10 |
| Antihistamine | 0/10 | 1/10 |
| Hormonal contraceptives | 3/10 | 0/10 |
Values are means ± SE; n, number of participants. MET, metabolic equivalent of task; HDL, high-density lipoprotein; LDL, low-density lipoprotein. *P < 0.05 vs. young adults.